ReviewPediatric health, medicine and therapeutics2018
Subacute sclerosing panencephalitis - current perspectives.
Review in Pediatric health, medicine and therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 68 citations in OpenAlex.
- Long-term survival (≥2 years) in subacute sclerosing panencephalitis: a systematic review of prolonged survivors.Encephalitis (Seoul, Korea) · 2026Article
- The Anti-Vaccine Legacy: Re-Emergence of Subacute Sclerosing Panencephalitis in Children.NeuroSci · 2026Article
- Uncommon Presentation of Subacute Sclerosing Panencephalitis: Two Cases of Rapidly Progressive Parkinsonism.Journal of movement disorders · 2026Article
- Progressive neurological decline in a measles survivor: A case report of subacute sclerosing panencephalitis in Zambia.IDCases · 2026Article
- Subacute sclerosing panencephalitis as a re-emerging condition due to low vaccination coverage: a case-series.Italian journal of pediatrics · 2025Article
- An early diagnostic tool for subacute sclerosing panencephalitis: Sleep-deprived electroencephalography.Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi · 2025Article
- Subacute Sclerosing Panencephalitis: Impact on Public Health, Current Insights, and Future Perspectives.Brain and behavior · 2025Review
- Viruses and the Brain-A Relationship Prone to Trouble.Viruses · 2025Review
- The Rare Case Presentation of Adult-Onset Fulminant Subacute Sclerosing Panencephalitis in a 24-Year-Old Male.Cureus · 2024Article
- Article
- SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model.Cell reports. Medicine · 2024Article
- Rubella virus chronic inflammatory disease and other unusual viral phenotypes in inborn errors of immunity.Immunological reviews · 2024Review
- Subacute Sclerosing Panencephalitis in a 63-Year-Old Woman Presenting as Generalized Choreoathetosis.The Neurohospitalist · 2023Article
- Periodic Laughter-like Episodes in Subacute Sclerosing Panencephalitis-Is it Gelastic Myoclonus?Movement disorders clinical practice · 2023Article
- Article
- Low glycemic index therapy in children with sub-acute sclerosing panencephalitis (SSPE): an experience from a measles-endemic country.Frontiers in nutrition · 2023Article
- Measles Induced Encephalitis: Recent Interventions to Overcome the Obstacles Encountered in the Management Amidst the COVID-19 Pandemic.Diseases (Basel, Switzerland) · 2022Review
- Article
- Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas.Current treatment options in neurology · 2022Review
- Clinical Spectrum of Movement Disorders in Neurology Inpatients in a Tertiary Care Centre.Journal of neurosciences in rural practice · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subacute sclerosing panencephalitis is a progressive neurodegenerative disease. It usually occurs 7-10 years after measles infection. The clinical course is characterized by progressive cognitive decline and behavior changes followed by focal or generalized seizures as well as myoclonus, ataxia, visual disturbance, and later vegetative state, eventually leading to death. It is diagnosed on the basis of Dyken's criteria. There is no known cure for subacute sclerosing panencephalitis to date, but it is preventable by ensuring that an effective vaccine program for measles is made compulsory for all children younger than 5 years in endemic countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.